Type 2 Diabetes Mellitus in Youth Exposed to Antipsychotics
Author(s) -
Britta Galling,
Alexandra Roldán,
René Ernst Nielsen,
Jimmi Nielsen,
Tobias Gerhard,
Maren Carbon,
Brendon Stubbs,
Davy Vancampfort,
Marc D. Binder,
Mark Olfson,
Kai G. Kahl,
Andrés Martin,
Jeff J. Guo,
HsienYuan Lane,
FungChang Sung,
Chun-Hui Liao,
Celso Arango,
Christoph U. Correll
Publication year - 2016
Publication title -
jama psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.531
H-Index - 365
eISSN - 2168-6238
pISSN - 2168-622X
DOI - 10.1001/jamapsychiatry.2015.2923
Subject(s) - medicine , psycinfo , type 2 diabetes mellitus , antipsychotic , meta analysis , psychiatry , incidence (geometry) , pediatrics , medline , diabetes mellitus , schizophrenia (object oriented programming) , endocrinology , physics , optics , political science , law
Antipsychotics are used increasingly in youth for nonpsychotic and off-label indications, but cardiometabolic adverse effects and (especially) type 2 diabetes mellitus (T2DM) risk have raised additional concern.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom